Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Auteur de référence en rhumatologie
27 articles scientifiques publiés — un praticien à la pointe de la recherche
Cabinet de groupe — continuité de soins
Plusieurs praticiens dans le même cabinet — un confrère peut prendre le relais en cas d'absence
Disponibilité géographique
6 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
131.5 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
32
32 articles ont été cités au moins 32fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
3 203
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
98
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
66
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Magnetization reversal in TmCr1−xCoxO3 perovskite solid solutions studied by Monte Carlo simulations
2025ArticleThe Journal of Chemical Physics
Band structure, magneto-Seebeck and magnetoresistance at the para-to ferri-magnetic transition in the Sr2FeReO6 double perovskite
2025ArticleSolid State Sciences
Mn3−xZnxTa2O8: Inducing multiferroelectricity in a linear magnetoelectric material
2025ArticleJournal of Applied Physics
Repenser le travail comme lieu d’émancipation
2025ArticleChroniques du Travail
Cationic disorder effect on the structural and magnetic properties in SmCr 1− x Fe x TiO 5
2025ArticleJournal of Materials Chemistry C
Exploring thermal and elastic properties of Ca 10 Ni 0.5 (VO 4 ) 7 : a study involving the use of synchrotron radiation facilities
2025ArticleCrystEngComm
Structural and magnetic properties of SmCrTi O 5
2024ArticlePhysical Review B
Enhancement of TN induced by magnetic dilution in the linear magnetoelectric Mn4Nb2O9
2024ArticleApplied Physics Letters
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
CH ANNECY-GENEVOIS SITE ANNECY
1 AV DE L'HOPITAL BP 90074, 74370 EPAGNY METZ TESSY
CABINET DU DR CHRISTINE MARTIN
SCM SCANNER D'ANNEMASSE 3 PASSAGE JEAN MOULIN, 74100 ANNEMASSE
EML IRM 74 - SITE ANNECY CESIERE
18 R DE LA CESIERE ZI VOVRAY, 74000 ANNECY
SCP DE MEDECINS FOUSSADIER-MARTIN-DEMIAUX
RUE ANDREVETAN, 74800 ROCHE SUR FORON (LA)
EML IRM 74 - SITE NANGY
ZA DES RANAUDES, 74380 NANGY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
European journal of endocrinology · 2023
Abstract Objective Drugs targeting the glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) are emerging as treatments for type-2 diabetes and obesity. GIP acutely decreases serum markers of bone resorption and transiently increases bone formation markers in short-term clinical investigations. However, it is unknown whether GIP acts directly on bone cells to mediate these effects. Using a GIPR-specific antagonist, we aimed to assess whether GIP acts directly on primary human osteoclasts and osteoblasts. Methods Osteoclasts were differentiated from human CD14+ monocytes and osteoblasts from human bone. GIPR expression was determined using RNA-seq in primary human osteoclasts and in situ hybridization in human femoral bone. Osteoclastic resorptive activity was assessed using microscopy. GIPR signaling pathways in osteoclasts and osteoblasts were assessed using LANCE cAMP and AlphaLISA phosphorylation assays, intracellular calcium imaging and confocal microscopy. The bioenergetic profile of osteoclasts was evaluated using Seahorse XF-96. Results GIPR is robustly expressed in mature human osteoclasts. GIP inhibits osteoclastogenesis, delays bone resorption, and increases osteoclast apoptosis by acting upon multiple signaling pathways (Src, cAMP, Akt, p38, Akt, NFκB) to impair nuclear translocation of nuclear factor of activated T cells-1 (NFATc1) and nuclear factor-κB (NFκB). Osteoblasts also expressed GIPR, and GIP improved osteoblast survival. Decreased bone resorption and improved osteoblast survival were also observed after GIP treatment of osteoclast–osteoblast co-cultures. Antagonizing GIPR with GIP(3–30)NH2 abolished the effects of GIP on osteoclasts and osteoblasts. Conclusions GIP inhibits bone resorption and improves survival of human osteoblasts, indicating that drugs targeting GIPR may impair bone resorption, whilst preserving bone formation.
JCI insight · 2022
Secreted phospholipase A 2 -IIA (sPLA 2 -IIA) hydrolyzes phospholipids to liberate lysophospholipids and fatty acids. Given its poor activity toward eukaryotic cell membranes, its role in the generation of proinflammatory lipid mediators is unclear. Conversely, sPLA 2 -IIA efficiently hydrolyzes bacterial membranes. Here, we show that sPLA 2 -IIA affects the immune system by acting on the intestinal microbial flora. Using mice overexpressing transgene-driven human sPLA 2 -IIA, we found that the intestinal microbiota was critical for both induction of an immune phenotype and promotion of inflammatory arthritis. The expression of sPLA 2 -IIA led to alterations of the intestinal microbiota composition, but housing in a more stringent pathogen-free facility revealed that its expression could affect the immune system in the absence of changes to the composition of this flora. In contrast, untargeted lipidomic analysis focusing on bacteria-derived lipid mediators revealed that sPLA 2 -IIA could profoundly alter the fecal lipidome. The data suggest that a singular protein, sPLA 2 -IIA, produces systemic effects on the immune system through its activity on the microbiota and its lipidome.
Children (Basel, Switzerland) · 2023
Holoprosencephaly (HPE) is the most common malformation of the prosencephalon in humans. It is characterized by a continuum of structural brain anomalies resulting from the failure of midline cleavage of the prosencephalon. The three classic subtypes of HPE are alobar, semilobar and lobar, although a few additional categories have been added to this original classification. The severity of the clinical phenotype is broad and usually mirrors the radiologic and associated facial features. The etiology of HPE includes both environmental and genetic factors. Disruption of sonic hedgehog (SHH) signaling is the main pathophysiologic mechanism underlying HPE. Aneuploidies, chromosomal copy number variants and monogenic disorders are identified in a large proportion of HPE patients. Despite the high postnatal mortality and the invariable presence of developmental delay, recent advances in diagnostic methods and improvements in patient management over the years have helped to increase survival rates. In this review, we provide an overview of the current knowledge related to HPE, and discuss the classification, clinical features, genetic and environmental etiologies and management.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2024 · Journal Article
Bémer P, Aubry A, Schramm F, Koebel C, et al.
Military medicine · 2024 · Journal Article
Martin CL, Nocera M, Mercer J, Marshall SW, et al.
Antioxidants (Basel, Switzerland) · 2024 · Journal Article
Maalouly G, Martin CM, Baz Y, Saliba Y, et al.
Palliative medicine · 2024 · Randomized Controlled Trial
Bock MA, Macchi ZA, Harrison KL, Katz M, et al.
Infectious diseases and therapy · 2024 · Journal Article
Appaneal HJ, LaPlante KL, Lopes VV, Martin C, et al.
JAMA neurology · 2024 · Randomized Controlled Trial
Kluger BM, Katz M, Galifianakis NB, Pantilat SZ, et al.
Journal of pain and symptom management · 2024 · Journal Article
Mahes A, Macchi ZA, Martin CS, Katz M, et al.
Bone reports · 2023 · Journal Article
Badr S, Cotten A, Mentaverri R, Lombardo D, et al.
Clinical genetics · 2023 · Journal Article
Dana J, Dorval G, Martin CS, Belhous K, et al.
Frontiers in endocrinology · 2023 · Journal Article
Badr S, Dapvril H, Lombardo D, Khizindar H, et al.
International journal of environmental research and public health · 2023 · Journal Article
Kirk AB, DeStefano A, Martin A, Kirk KC, et al.
European journal of endocrinology · 2023 · Journal Article
Hansen MS, Søe K, Christensen LL, Fernandez-Guerra P, et al.
International journal of molecular sciences · 2022 · Journal Article
Fenton CG, Crastin A, Martin CS, Suresh S, et al.
Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022 · Journal Article
Heard BJ, Barton KI, Abubacker S, Chung M, et al.
Journal of neurophysiology · 2022 · Journal Article
Simon OB, Rojas DC, Ghosh D, Yang X, et al.
PloS one · 2026 · Journal Article
Sadjadi M, von Groote T, Krone S, Schöne LM, et al.
Annals of diagnostic pathology · 2024 · Journal Article
Khalil MA, Habibian L, Martin C, Semaan K, et al.
Global spine journal · 2022 · Journal Article
Paz RD, Henríquez MS, Melián KA, Martin CB
Current atherosclerosis reports · 2023 · Journal Article
Schratz LM, Larkin O, Dos Santos N, Martin C
Children (Basel, Switzerland) · 2023 · Journal Article
Malta M, AlMutiri R, Martin CS, Srour M
Clinical kidney journal · 2023 · Journal Article
Boud'hors C, Riou J, Fage N, Samoreau C, et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023 · Multicenter Study
Samoreau C, Piccoli GB, Martin C, Gatault P, et al.
International journal of environmental research and public health · 2023 · Journal Article
Montesó-Curto P, Toussaint L, Kueny A, Ruschak I, et al.
International ophthalmology clinics · 2022 · Journal Article
Martin CA, Crowell EL
Frontiers in endocrinology · 2021 · Journal Article
Martin CS, Cooper MS, Hardy RS
Journal of geriatric oncology · 2025 · Journal Article
Theodoulou E, Martin C, Morgan J, Turner O, et al.
JCI insight · 2022 · Journal Article
Doré E, Joly-Beauparlant C, Morozumi S, Mathieu A, et al.
Children (Basel, Switzerland) · 2023 · Journal Article
Malta M, AlMutiri R, Martin CS, Srour M
Inelastic neutron scattering study of alpha-SrCr2O4
Inelastic scattering study of CaFe2O4
CSD 1995169: Experimental Crystal Structure Determination
Related Article: Stéphane Caubergh, Nami Matsubara, Françoise Damay, Antoine Maignan, François Fauth, Pascal Manuel, Dmitry D. Khalyavin, Bénédicte Vertruyen, Christine Martin|2020|Inorg.Chem.|59|9798|doi:10.1021/acs.ino
Additional file 7 of The velvet worm brain unveils homologies and evolutionary novelties across panarthropods
Additional file 7: Data S2. Image stack showing aligned greyscale light micrographs of Azan-stained sections of E. rowelli head used for segmentation
sj-pptx-2-pmj-10.1177_02692163231219923 – Supplemental material for Does a novel community-based outpatient palliative care intervention for Parkinson’s disease and related disorders improve care? Qualitative results from patients and care partners
Supplemental material, sj-pptx-2-pmj-10.1177_02692163231219923 for Does a novel community-based outpatient palliative care intervention for Parkinson’s disease and related disorders improve care? Qualitative results from
Does a novel community-based outpatient palliative care intervention for Parkinson’s disease and related disorders improve care? Qualitative results from patients and care partners
Background:Palliative care has the potential to address significant unmet needs in people with Parkinson’s disease and related disorders, but models that rely on in-person specialty palliative care teams have limited sca
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).